WG2: Pharmacological regulation and drugs

Activities

This WG will coordinate all aspects along the pipeline of drug development, including preclinical studies. All the knowledge gathered and tools developed in WG1 will serve to guide the identification of existing and new compounds that target NRF2 and influence the course of selected NCDs in cellular and animal models. WG2 will strive for standardizing procedures and protocols to maximize the reproducibility of results, and for selecting accurate disease animal models.

Task

Members

Agnes S. Klar

Ahmet Can Timucin

Ana Casas Guijarro

Ana Cipak Gasparovic

Andreas Daiber

Ángel Juan García Yagüe

Anton Terasmaa

Bilge Debelec Butuner

Biljana Miova

Bruno Ramos-Molina

Camillo Rosano

Catalina Anca Cucos

Chakradhara Rao S Uppugunduri

Christina Morgenstern

Claudia Santos

Diego Lastra

DJORDJE MILJKOVIC

Efrosyni Paraskeva

Elena Rafailovska

Eugenia Carvalho

Eva Cano

George Spyrou

Gerasimos Sykiotis

Gina Manda

GUNAY YETIK ANACAK

Harry van Goor

Helena Vieira

huseyin Istanbullu

Inês V Silva

Ioannis P. Trougakos

Irina Milisav

Isabel Lastres-Becker

IVANA STOJANOVIC

Joana Loureiro

Joana Miranda

Joana S. Rodrigues

Jordi Muntané

Jose Jimenez Villegas

Josep Julve

Juan Antonio Moreno

Juan Carlos Escola Gil

Kari Espolin Fladmark

Kateřina Valentová

Katja Kanninen

Kattri-Liis Eskla

Lidija Milkovic

Liliya Mihaylova (Vasileva)

Mª Luisa Ferrándiz

Maria Carmo Pereira

Maria Teresa Bayo Jimenez

Maria Teresa Cruz

Marisa Andreia Carvalho de Freitas

Michel-Edwar Mickael

Miguel Seabra

Miguel Soares

Milen Georgiev

Milica Lazarevic

Neda Djedovic

Nesrin Kartal Ozer

Niki Chondrogianni

Petek BALLAR KIRMIZIBAYRAK

Rafael León

Raquel Fernández Ginés

Roberta Foresti

Roberto Motterlini

RON KOHEN

Sandra Tenreiro

Sara Zakaria

Sibel Kalyoncu Uzunlar

Silvia Giordani

Srdjan Bjedov

Susana Cadenas

Suzana Stanisavljevic

Tilman Grune

Tuğba BOYUNEGMEZ TUMER

Ugne Jonavice

Vasco Branco

Vera Marisa Costa

Yahya Sohrabi

Zorica Stojic-Vukanic